October 24th 2024
How emerging biotech companies can create fruitful partnerships between home office commercial teams and the field force to enable this intelligence gathering, while driving commercial success.
October 18th 2024
A panel dives into the current and future outlook of healthcare policies.
October 16th 2024
The session dives into the obstacles surrounding data usability, mandate compliance, initial adoption, and limitations in this arena.
October 15th 2024
The conference’s opening keynote sets the scene for 2025 and the years to come.
September 30th 2024
Why this trend is occurring and ways that drugmakers are pivoting in order to remedy the situation.
New consulting resources for contract management, incentive compensation and regulatory
TGaS Advisors expands its roster of services
Vaccines manufacturers wrestle with public health policy
Good growth is occurring in the vaccine business, despite the hurdles of public perceptions and public-health funding shortfalls
The impact of the anti-vaccination lobby
Observational Research: Choosing the right research approach for the right question
Industry hit a record low number of FDA OPDP actions in 2015
Office of Prescription Drug Promotion finds little to complain about
A Conversation with Bill Roth, Blue Fin Group
CMS publishes the long-awaited AMP rule
'Average Manufacturer Price' is now a mostly settled matter
Mind your "Q"s: QPharma acquires Qforma
Combination expands breadth of commercialization and compliance services
FDA approved 45 new drugs in 2015--a new recent record
List includes 21 new orphan drugs, and of the 45, 15 are cold chain products
Dissecting the speed-to-therapy question
Are hubs a help or hindrance in getting patients on therapy?
Pediatric drug market finds its own pathway
Even with legislative incentives, pharma manufacturers struggle to cost-justify pediatric innovation
Deloitte healthcare consumer survey: more trust in pharma; more interaction over healthcare costs
Biennial survey finds growing awareness of information options by consumers
TMS Health steps more deeply into specialty services with acquisition of inVentiv's Patient Access Solutions (iPAS)
Xerox subsidiary expands its call-center operations to include specialty reimbursement services
Pharma is under-managing its multi-channel marketing efforts
Survey shows that most digital channels are still experiments with little oversight or follow-through
The business of orphan drugs is booming
With competing products and pricing pressure, the rare disease market is starting to resemble the conventional drug market
Shifts in the retail pharmacy landscape
Latest SK&A pharmacy data outlines retail channel
Moving the needle on diabetes
While the biopharma industry continues to develop better treatment options, there is a stronger focus on more intensive patient engagement
Patient-centric support for specialty drug therapy--a new model to address the needs of a changing patient population
Demand for McKesson Patient Relationship Solutions grows; also expanded AccessHealth services for pharmacies
Company will open a second call center, in Atlanta, GA, to provide support for patient-engagement and adherence programs
IMS Health centralizes commercialization services in a Customer Engagement Hub
Adds another acquisition, Dataline Software, to beef up real-world evidence (RWE) capabilities
When worlds collide: Grappling with the rising therapeutic value--and rising cost--of cancer drugs
As new cancer drugs with promising efficacy but brutal costs enter the market, providers, payers and manufacturers are strategizing new payment approaches
TrialCard takes closer aim at market access solutions
Leading copay-coupon provider expands its patient services with private equity help
New EMD Serono Specialty Digest finds 'site of care' management a top payer priority
Do you know your J codes?
HealthPrize touts its success with 'gamification' in adherence programs
Company uses online media to promote fill rates by more than 50%
Alliance Life Sciences partners with Revitas to better manage pharma revenue practices
1.5-10% improvement in 'revenue capture' is possible
Doximity crosses 50% line of engagement with physician population
'Stay tuned' for interactions directly with pharma companies, says CEO Jeff Tangney
Nurses remain the top most trusted profession, says annual Gallup poll
Pharmacists' ranking, continuing a two-year decline, is now neck-and-neck with doctors
Dohmen acquires Siren Interactive, a rare diseases agency
Acquisition builds on Dohmen's rare-disease business
The evolving CSO landscape
Outsourced field sales is becoming only part of what CSOs are offering their pharma clients
Veeva, Cegedim announce new partnerships and IT alliances in pharma sales force automation
Publicis Touchpoint Solutions does a deal with Cegedim Relationship Management